Abrupt regression of a meningioma after discontinuation of cyproterone treatment
- PMID: 20053802
- PMCID: PMC7966109
- DOI: 10.3174/ajnr.A1978
Abrupt regression of a meningioma after discontinuation of cyproterone treatment
Abstract
The multiplicity of meningiomas or abrupt lesion growth in patients treated with cyproterone acetate suggests that this progestative treatment may promote lesion growth. We report the rapid regression of an incidental meningioma after discontinuation of a 10-year cyproterone acetate treatment. This unique observation suggests that conservative management of meningiomas may be the best option among users of high doses of cyproterone acetate, given that spontaneous regression may occur after hormonal treatment discontinuation.
Figures
References
-
- Froelich S, Dali-Youcef N, Boyer P, et al. . Does cyproterone acetate promote multiple meningiomas? In: Proceedings of the 10th European Congress of Endocrinology, Berlin, Germany. May 3–7, 2008
-
- Wigertz A, Lonn S, Hall P, et al. . Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 2008;17:2663–70 - PubMed
-
- Smith JS, Quinones-Hinojosa A, Harmon-Smith M, et al. . Sex steroid and growth factor profile of a meningioma associated with pregnancy. Can J Neurol Sci 2005;32:122–27 - PubMed
-
- Blankenstein MA, Verheijen FM, Jacobs JM, et al. . Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 2000;65:795–800 - PubMed
-
- Hatiboglu MA, Cosar M, Iplikcioglu AC, et al. . Sex steroid and epidermal growth factor profile of giant meningiomas associated with pregnancy. Surg Neurol 2008;69:356–62 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources